Cancer Resources

The Cord Blood Center

Source: The Cord Blood Center
Date: May 13, 2015
At, we want to provide you and your family with relevant information on cord blood, banking options and emerging research, so you can make the best decision possible for your family. Our organization promotes awareness for current and future stem cell treatments, and we are committed to being the most comprehensive and up-to-date resource available for mothers and families considering cord blood.

Mesothelioma Survival Rate

Source: Mesothelioma Guide
Date: October 23, 2014
Mesothelioma is a rare form of cancer that is caused by asbestos exposure. Patients with mesothelioma can refer to Mesothelioma Guide for support and information about the latest treatments and research efforts that can help improve their survival rate and prognosis. Through clinical trials and finding a mesothelioma specialist, patients can prolong and sometimes outlive their life expectancy.

The Weil Foundation

Source: The WEIL Foundation
Date: March 22, 2011
The Weil Foundation is a 501(c)(3) non-profit organization that receives tax-deductible donations which it uses to make grants to advance integrative medicine. Since its inception in 2005, the Weil Foundation has given out more than $2 million in grants and gifts to medical centers and other non-profit organizations nationwide. Our shared goal is nothing less than to transform health care.
Categories: Integrative Specific

Cogmed Working Memory Training

Source: Cogmed Working Memory Training
Date: February 25, 2011
Cogmed Working Memory Training

Leukemia & Lymphoma Society

Source: Leukemia & Lymphoma Society
Date: January 5, 2011
Contact: Sharon Cohan, LCSW 561-775-9954

Cancer Alliance of Help & Hope

Source: Cancer Alliance of Help & Hope
Date: January 5, 2011

South Florida Affiliate of Susan G. Komen for the Cure

Source: Komen South Florida
Date: December 1, 2010
The South Florida Affiliate of Susan G. Komen for the Cure has a service area of Palm Beach, Martin and St. Lucie counties. We partner with many local nonprofit organizations to help raise breast cancer awareness and provide much needed funds.
South Florida Affiliate of Susan G. Komen for the Cure

Cancer Net

Source: Cancer Net
Date: December 1, 2010
Cancer.Net brings the expertise and resources of the American Society of Clinical Oncology (ASCO), the voice of the world’s cancer physicians, to people living with cancer and those who care for and care about them. ASCO is composed of more than 28,000 oncologists globally who are the leaders in advancing cancer care. All the information and content on Cancer.Net was developed and approved by the cancer doctors who are members of ASCO, making Cancer.Net an up-to date and trusted resource for cancer information. Cancer.Net is supported by The ASCO Cancer Foundation, which provides funding for cutting-edge cancer research, professional education, and patient and family support.


Source: Livestrong
Date: December 1, 2010
We believe that unity is strength, knowledge is power and attitude is everything. Our programs, awareness events and advocacy work are the heart of what we do and our leaders and donors provide both the vision and the support for LIVESTRONG to carry out our mission. Explore our survivorship programs to understand the ways in which LIVESTRONG is working to improve the cancer experience.

National Cancer Institute

Source: National Cancer Institute
Date: December 1, 2010
The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice.